<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02039830</url>
  </required_header>
  <id_info>
    <org_study_id>CRC01:GROUP</org_study_id>
    <secondary_id>CIHR258993</secondary_id>
    <nct_id>NCT02039830</nct_id>
  </id_info>
  <brief_title>Group Versus Individual Physiotherapy for Urinary Incontinence in Aging Women</brief_title>
  <acronym>GROUP</acronym>
  <official_title>Group Physiotherapy Compared to Individual Physiotherapy to Treat Urinary Incontinence in Aging Women: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The recommended treatment for urinary incontinence (UI) in women is individualised pelvic
      floor muscle (PFM) training, a costly and resource-intense approach; one Canada is currently
      unable to meet. This non-inferiority randomized control trial seeks to determine if
      group-based PFM training is as effective as individualised PFM training for treating UI in
      women 65 and over, and to establish the cost-effectiveness of both. Demonstrating that
      group-based treatment is at least as good as individualised one-on-one treatment and more
      cost-effective would warrant including group-based PFM training as a first-line UI treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The incidence of urinary incontinence (UI) in women increases with age but, unbeknownst to
      many, it is not a normal part of aging and, in most cases, can be effectively treated. Yet
      today, the majority of senior women go untreated due to a lack of both human and financial
      resources. In Canada, there are currently 3 million senior women. Over the next 15 years
      their numbers are expected to grow significantly, as will the incidence of UI. The number of
      senior women requiring treatment, let alone the future demand, makes it imperative that more
      cost-effective treatments be identified. The prevalence of UI in community- dwelling women 65
      and over is high - 55% experience stress or urge UI, or even both, and of these, 20 to 25%
      are classified as having severe symptoms. Not only is UI a serious medical condition but it
      is also undeniably a social problem, engendering embarrassment and negative self-perceptions.
      It is associated with reduced social interactions and physical activities, with poor
      self-rated health, impaired emotional and psychological well-being and impaired sexual
      relationships. Moreover, it doubles women's risk of being admitted to a nursing home,
      independent of age or the presence of any other co-morbid conditions. It severely undermines
      a woman's right to healthy aging. Without doubt, this pervasive and serious condition
      requires immediate attention. Demographics, the negative impact on older women's functional
      autonomy and the current unmet treatment needs alone renders improving continence care for
      older women a priority for the Institute of Aging. This study aims to evaluate if group-
      based physiotherapy treatment is at least as good as individualized one-on-one physiotherapy
      treatment for treating urinary incontinence in aging women. The treatment efficacy will be
      assessed in 364 women (aged 60 years and older) suffering from stress or mixed urinary
      incontinence and recruited in 4 hospitals and in the community.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent reduction in the number of UI episodes</measure>
    <time_frame>at recruitment, 13 weeks after recruitment and 12 months after recruitment</time_frame>
    <description>evaluated with a 7-day bladder diary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the symptoms and the degree to which UI-associated symptoms are troubling or bothersome</measure>
    <time_frame>at recruitment, 13 weeks after recruitment and 12 months after recruitment</time_frame>
    <description>evaluated using the 24h PAD test, International Consultation on Incontinence questionnaire on urinary incontinence (ICIQ-UI short form (symptoms), ICIQ-Nocturia (symptoms), ICIQ-Vaginal Symptoms(symptoms), ICIQ-FemaleLowerUrinaryTractSsex (symptoms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in UI related QOL</measure>
    <time_frame>at recruitment, 13 weeks after recruitment and 12 months after recruitment</time_frame>
    <description>evaluated using the ICIQ-Lower UrinaryTract Symptoms quality of life(QOL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in UI related self-efficacy</measure>
    <time_frame>at recruitment, 13 weeks after recruitment and 12 months after recruitment</time_frame>
    <description>evaluated using the Geriatric self-efficacy index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in UI related self-efficacy</measure>
    <time_frame>13 weeks after recruitment (recollection of what was before recruitment and what is now) and 12 months after recruitment</time_frame>
    <description>evaluated using the Broom PFM Self-efficacy scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs related to interventions</measure>
    <time_frame>at recruitment, 13 weeks after recruitment and 12 months after recruitment</time_frame>
    <description>evaluated using the modified Dowel-Bryant Incontinence Cost Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in anthropometric measurements</measure>
    <time_frame>at recruitment, 13 weeks after recruitment and 12 months after recruitment</time_frame>
    <description>evaluated using height and weight measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in PFM function</measure>
    <time_frame>at recruitment, 13 weeks after recruitment and 12 months after recruitment</time_frame>
    <description>evaluated using digital palpation (Oxford scale), Vaginal atrophy index, dynamometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in PFM morphology</measure>
    <time_frame>at recruitment, 13 weeks after recruitment and 12 months after recruitment</time_frame>
    <description>evaluated using transperineal US</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported improvement and satisfaction</measure>
    <time_frame>13 weeks after recruitment and 12 months after recruitment</time_frame>
    <description>evaluated using Patient global impression of improvement (PGI-I), Benefit and willingness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to intervention and home exercises</measure>
    <time_frame>after recruitment (once/week during 12 weeks), 13 weeks after after recruitment, 6 months after recruitment, at 9 months after recruitment, 12 months after recruitment</time_frame>
    <description>evaluated using homemade questionnaire including attendance to intervention and assiduity to home exercises program</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">364</enrollment>
  <condition>Urinary Incontinence</condition>
  <condition>Urinary Stress Incontinence</condition>
  <arm_group>
    <arm_group_label>Group physiotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 weekly treatment visit + daily home exercise program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Individual one-on-one physiotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 weekly treatment visit + daily home exercise program</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Group physiotherapy</intervention_name>
    <description>Multimodal Group physiotherapy 12 weeks of weekly Group physiotherapy treatments including education and pelvic floor muscle exercises</description>
    <arm_group_label>Group physiotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Individual one-on-one physiotherapy</intervention_name>
    <description>Multimodal Individual physiotherapy 12 weeks of weekly Individual physiotherapy treatments including education and pelvic floor muscle exercises</description>
    <arm_group_label>Individual one-on-one physiotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  60 years or older

          -  suffering from stress urinary incontinence (SUI) or mixed urinary incontinence (MUI)
             symptoms

          -  at least 3 urinary incontinence episodes per week x 3 months or more

          -  ambulatory without the need of assisted device

          -  understand French or English instruction

          -  hormonal replacement stable for 6 months

        Exclusion Criteria:

          -  present risk factors known to interfere with the effects of PFM training

          -  &gt;2 degree Pop-Q

          -  body mass index &gt;35

          -  chronic constipation

          -  have received physiotherapy or surgical treatment within the last year
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chantal Dumoulin, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chantal Dumoulin, Ph.D.</last_name>
    <phone>514 340-3540</phone>
    <phone_ext>4153</phone_ext>
    <email>chantal.dumoulin@umontreal.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joanie Mercier, M.Sc.</last_name>
    <phone>514 340-3540</phone>
    <phone_ext>4129</phone_ext>
    <email>joanie.mercier.1@umontreal.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Laboratoire incontinence et vieillissement CRIUGM</name>
      <address>
        <city>Montr√©al</city>
        <state>Quebec</state>
        <zip>H3W 1W5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chantal Dumoulin, Ph.D.</last_name>
      <phone>514 340-3540</phone>
      <phone_ext>4153</phone_ext>
      <email>chantal.dumoulin@umontreal.ca</email>
    </contact>
    <contact_backup>
      <last_name>Joanie Mercier, M.Sc.</last_name>
      <phone>514 340-3540</phone>
      <phone_ext>4129</phone_ext>
      <email>joanie.mercier.1@umontreal.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Chantal Dumoulin, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2013</study_first_submitted>
  <study_first_submitted_qc>January 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2014</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal</investigator_affiliation>
    <investigator_full_name>Chantal Dumoulin</investigator_full_name>
    <investigator_title>Dr Chantal Dumoulin, researcher and laboratory director</investigator_title>
  </responsible_party>
  <keyword>female</keyword>
  <keyword>aging</keyword>
  <keyword>physiotherapy</keyword>
  <keyword>pelvic floor</keyword>
  <keyword>rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

